查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967608

黏合劑市場－全球產業規模、佔有率、趨勢、機會、預測：按應用、類型、形狀、地區和競爭格局分類，2021-2031年

Dural Adhesive Agent for Surgical Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Type (Polyethylene glycol, Others ), By Form,,By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球外科硬腦膜黏合劑市場預計將從 2025 年的 2.1331 億美元成長到 2031 年的 2.9597 億美元，複合年成長率為 5.61%。

這些專用硬腦膜黏合劑在脊椎和神經外科手術中發揮著至關重要的作用，它們作為外科密封劑和黏合劑，密封硬腦膜以防止腦脊髓液滲漏。市場成長趨勢主要受全球顱腦和脊椎手術頻率增加的推動，而這又主要是由於人口老化和需要手術治療的創傷性損傷病例不斷增加所致。此外，減少術後併發症和縮短患者恢復時間等臨床需求也強烈支持使用這些輔助密封劑，而不是僅依賴傳統的縫合技術。

市場概覽
預測期 2027-2031
市場規模：2025年 2.1331億美元
市場規模：2031年 2.9597億美元
複合年成長率：2026-2031年 5.61%
成長最快的細分市場 顱骨手術
最大的市場 北美洲

美國脊椎註冊中心的數據凸顯了這一日益成長的需求，預計到2025年，脊椎手術量將年增17.86%。儘管成長強勁，但市場擴張仍面臨一個重大障礙：先進的合成和生物黏合劑產品成本高昂。這一經濟障礙限制了預算緊張的發展中地區和醫療系統採用這些產品，從而阻礙了市場滲透。

市場促進因素

脊椎和神經系統疾病的日益普遍是全球硬膜黏合劑市場的主要促進因素，因為這些疾病通常需要進行複雜的手術，而硬膜修復在手術中至關重要。脊髓損傷和中樞神經系統惡性腫瘤的高發生率直接增加了需要安全密封以防止腦脊髓液滲漏的手術數量。根據美國癌症協會於2025年1月發布的《2025年癌症事實與數據》報告，美國預計將診斷出24,820例脊髓或腦部惡性腫瘤病例。全球創傷數據也印證了這龐大的患者數量。發表於2025年1月《老化研究評論》的一項題為《全球、區域和國家脊髓損傷負擔》的研究報告指出，在最近一個分析年份，全球脊髓損傷病例數達到574,502例，凸顯了持續尋求能夠最大限度降低術後風險的手術解決方案的必要性。

此外，合成和生物相容性硬腦膜密封劑技術的創新正在加速市場接受度，滿足了臨床上對有效預防滲漏的迫切需求。與傳統縫合線相比，外科醫生擴大採用先進的水凝膠和基質，這些材料能夠增強組織黏附性並降低併發症率。這些最尖端科技的市場成功體現在領先的再生醫學解決方案提供者的財務表現。例如，Integra Life Sciences 在 2024 年 11 月發布的 2024 年第三季財報中指出，其組織技術部門（包括硬腦膜修復產品）的收入達到 1.101 億美元。這一數字凸顯了醫療機構在高品質黏合劑方面的大量投資，以確保最佳的康復效果並減少昂貴的再次入院。

市場挑戰

先進的合成和生物硬鋁黏合劑的高昂購置成本嚴重阻礙了其在全球外科手術中的廣泛應用。儘管這些產品具有明顯的臨床優勢，但其高昂的價格往往超出了許多醫療機構的預算，尤其是公共醫療系統和麵臨財政嚴格限制的發展中地區。因此，採購部門和外科醫生常常被迫選擇更經濟的替代方案，例如傳統縫合線，尤其是在常規手術中，因為在這些手術中，密封劑的額外成本並非絕對必要。

醫療產業營運成本的不斷上漲加劇了這種經濟壓力，限制了其購買高品質手術輔助器具的能力。根據美國醫院協會的數據，預計到2024年，醫院總支出將增加5.1%，這一數字比整體經濟通膨率高出數十億以金額為準。日益沉重的財務負擔迫使醫療機構採取嚴格的成本削減措施，這往往導致昂貴且非必要的醫療用品採購減少。因此，硬腦膜黏合劑生產商在進入那些價格敏感度高於對先進術後護理解決方案需求的市場時面臨挑戰。

市場趨勢

專為微創神經外科手術設計的施用器不斷革新，正在改變硬腦膜黏合劑的使用方式。隨著外科醫生擴大選擇鎖孔開顱術和經鼻內視鏡技術，傳統的注射器給藥方法已無法滿足進入深部狹窄手術通道的需求。為此，製造商推出了軟性可伸縮的導管式施用器和噴嘴。這些施藥器能夠將密封劑精確、可控制地應用於難以觸及的硬腦膜缺損處，且不會阻礙手術視野。這項發展滿足了操作簡便性和在狹小空間內高效操作的關鍵工作流程需求，直接推動了微創手術的發展。此類以使用者為中心的手術器械的商業性吸引力從主要市場參與者的財務表現中可見一斑。在2024年11月發布的2024年第三季財報中，百特國際公司公佈其先進外科業務部門的銷售額為2.72億美元，年增7%，這主要得益於市場對其密封劑和止血產品組合的強勁需求。

同時，完全可生物分解和可生物吸收的配方正成為一種顯著趨勢，旨在改善長期術後效果。傳統的密封劑通常會留下永久性殘留物，而目前的趨勢是使用水凝膠基質，這種基質可在通常為30至45天的可預測時間內透過水解完全分解。這項特性對於避免殘留物壓迫神經組織的「佔位效應」至關重要，同時也能防止黏合劑在後續MRI掃描中錯誤地顯示腫瘤復發。永久性或滲透性的產品經常會遇到這種挑戰，這表明影像清晰度和「清潔」癒合正成為複雜顱腦和脊椎手術的先決條件。該領域對高度生物相容性和高性能解決方案的需求規模龐大。根據Medtronic公司於2024年5月發布的“2024年全年及第四季度財務業績報告”，該公司神經科學產品組合創造了94億美元的收入，這表明支持複雜神經系統修復的先進技術擁有廣闊的市場。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球外科黏合劑市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（顱腦手術、脊椎手術）
    • 按類型（聚乙二醇、其他（纖維蛋白黏合劑））
    • 按形式（密封膠、密封膜）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美外科黏合劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲黏合劑黏合劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區黏合劑黏合劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲黏合劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲黏合劑黏合劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球外科黏合劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medprin Biotech GmbH
  • Integra LifeSciences Corporation
  • Pramand LLC
  • Stryker Corporation
  • DuraStat, Inc.
  • Medtronic plc
  • Becton, Dickinson and Company
  • Regenity Biosciences
  • Baxter International, Inc.
  • Johnson & Johnson

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24109

The Global Dural Adhesive Agent for Surgical Market is projected to expand from USD 213.31 Million in 2025 to USD 295.97 Million by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 5.61%. These specialized dural adhesive agents serve as essential surgical sealants and glues during spinal and neurosurgical operations, functioning to seal the dura mater and avert cerebrospinal fluid leakage. The market's upward trajectory is largely propelled by an increasing global frequency of cranial and spinal surgeries, a trend driven by an aging demographic and a higher prevalence of traumatic injuries necessitating operative care. Furthermore, the clinical priority to reduce post-surgical complications and accelerate patient recovery times strongly favors the use of these adjunctive sealants over relying solely on traditional suturing techniques.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 213.31 Million
Market Size 2031USD 295.97 Million
CAGR 2026-20315.61%
Fastest Growing SegmentCranial Surgery
Largest MarketNorth America

Data from the American Spine Registry highlights this growing demand, recording a 17.86% surge in submitted spine procedures in 2025 compared to the prior year, signaling a strong increase in surgical volume. Despite this robust growth, market expansion faces a notable obstacle regarding the substantial costs linked to advanced synthetic and biological adhesive products. This financial barrier limits their widespread implementation within developing regions and healthcare systems operating under tight budget constraints, hindering broader market penetration.

Market Driver

The escalating prevalence of spinal and neurological disorders acts as the primary driver for the global dural adhesive agent market, as these conditions often require intricate surgeries where dural repair is essential. The high frequency of spinal injuries and central nervous system malignancies directly increases the number of procedures necessitating reliable sealing to prevent cerebrospinal fluid leaks. According to the 'Cancer Facts & Figures 2025' report by the American Cancer Society in January 2025, it was projected that 24,820 malignant tumors of the spinal cord or brain would be diagnosed in the United States. This significant patient load is further corroborated by global trauma data; a study published in Ageing Research Reviews in January 2025 titled 'Global, regional, and national burden of spinal cord injury...' noted that global spinal cord injury cases reached 574,502 in the latest analysis year, highlighting the persistent need for surgical solutions to minimize post-operative risks.

Furthermore, innovations in synthetic and biocompatible dural sealant technologies are hastening market acceptance by satisfying the urgent clinical requirement for effective leak prevention. Surgeons are progressively adopting advanced hydrogels and matrices that provide enhanced tissue adhesion and lower complication rates relative to conventional sutures. The market success of these cutting-edge technologies is reflected in the financial results of leading regenerative solution providers. For instance, Integra LifeSciences reported in its 'Third Quarter 2024 Financial Results' in November 2024 that its Tissue Technologies segment, which includes its dural repair products, achieved 110.1 million dollars in revenue. This figure underscores the substantial investment by healthcare providers in premium adhesive agents to secure optimal recovery outcomes and reduce costly hospital readmissions.

Market Challenge

The substantial acquisition costs linked to advanced synthetic and biological dural adhesives create a significant impediment to their ubiquitous adoption across the global surgical landscape. Although these products provide distinct clinical advantages, their premium price points often surpass the budgetary constraints of numerous healthcare facilities, especially within public health systems and developing regions subject to rigorous financial limits. Consequently, procurement departments and surgeons frequently encounter pressure to favor more economical alternatives, such as traditional sutures, particularly during routine operations where the additional cost of a sealant may not be considered strictly essential.

This economic pressure is exacerbated by increasing operational expenditures within the healthcare industry, which constrain the ability to purchase premium surgical adjuncts. Data from the American Hospital Association indicates that in 2024, total hospital expenses rose by 5.1%, a rate significantly exceeding general economic inflation. This mounting financial load forces medical institutions to adopt strict cost-containment measures, frequently leading to decreased procurement of expensive, non-mandatory medical supplies. As a result, dural adhesive manufacturers encounter challenges in expanding into markets where price sensitivity overrides the demand for sophisticated post-operative care solutions.

Market Trends

The evolution of applicators designed specifically for minimally invasive neurosurgery is reshaping how dural adhesive agents are utilized. With surgeons increasingly favoring keyhole craniotomies and endoscopic endonasal techniques, traditional syringe-based delivery methods have become insufficient for accessing deep, narrow surgical pathways. In response, manufacturers are launching flexible, extended catheter-based applicators and spray tips that enable the precise, controlled application of sealants in difficult-to-reach dural defects without obscuring the surgical field. This development addresses the vital workflow requirement for ease of use and efficiency in confined spaces, directly bolstering the growth of minimally invasive procedures. The commercial appeal of such user-focused surgical tools is evident in the financial performance of major market players; Baxter International Inc. reported in its 'Third Quarter 2024 Results' in November 2024 that its Advanced Surgery segment achieved sales of 272 million dollars, a 7% rise attributed to robust demand for its sealant and hemostat portfolio.

Concurrently, there is a marked transition toward fully biodegradable and bioabsorbable formulations engineered to enhance long-term post-surgical results. Unlike previous sealant generations that often left permanent residue, current trends favor hydrogel matrices that completely degrade through hydrolysis within a predictable period, usually between 30 and 45 days. This property is crucial for avoiding the "mass effect," wherein residual material compresses neural tissue, and for ensuring the adhesive does not simulate tumor recurrence on follow-up MRI scans, a frequent problem with permanent or radio-opaque products. This emphasis on imaging clarity and "clean" healing is becoming a prerequisite for complex cranial and spinal surgeries. The magnitude of the sector requiring these biocompatible, high-performance solutions is significant; Medtronic's 'Full Year and Fourth Quarter Fiscal 2024 Financial Results' from May 2024 revealed that its Neuroscience Portfolio generated 9.4 billion dollars in revenue, highlighting the extensive market for advanced technologies supporting intricate nervous system repairs.

Key Market Players

  • Medprin Biotech GmbH
  • Integra LifeSciences Corporation
  • Pramand LLC
  • Stryker Corporation
  • DuraStat, Inc.
  • Medtronic plc
  • Becton, Dickinson and Company
  • Regenity Biosciences
  • Baxter International, Inc.
  • Johnson & Johnson

Report Scope

In this report, the Global Dural Adhesive Agent for Surgical Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dural Adhesive Agent for Surgical Market, By Application

  • Cranial Surgery
  • Spinal Surgery

Dural Adhesive Agent for Surgical Market, By Type

  • Polyethylene glycol
  • Others (Fibrin Glue)

Dural Adhesive Agent for Surgical Market, By Form

  • Sealant Glue
  • Sealant Film

Dural Adhesive Agent for Surgical Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dural Adhesive Agent for Surgical Market.

Available Customizations:

Global Dural Adhesive Agent for Surgical Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dural Adhesive Agent for Surgical Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Cranial Surgery, Spinal Surgery)
    • 5.2.2. By Type (Polyethylene glycol, Others (Fibrin Glue))
    • 5.2.3. By Form (Sealant Glue, Sealant Film)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Dural Adhesive Agent for Surgical Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Type
    • 6.2.3. By Form
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dural Adhesive Agent for Surgical Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Form
    • 6.3.2. Canada Dural Adhesive Agent for Surgical Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Form
    • 6.3.3. Mexico Dural Adhesive Agent for Surgical Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Form

7. Europe Dural Adhesive Agent for Surgical Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Type
    • 7.2.3. By Form
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dural Adhesive Agent for Surgical Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Form
    • 7.3.2. France Dural Adhesive Agent for Surgical Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Form
    • 7.3.3. United Kingdom Dural Adhesive Agent for Surgical Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Form
    • 7.3.4. Italy Dural Adhesive Agent for Surgical Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Form
    • 7.3.5. Spain Dural Adhesive Agent for Surgical Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Form

8. Asia Pacific Dural Adhesive Agent for Surgical Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Type
    • 8.2.3. By Form
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dural Adhesive Agent for Surgical Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Form
    • 8.3.2. India Dural Adhesive Agent for Surgical Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Form
    • 8.3.3. Japan Dural Adhesive Agent for Surgical Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Form
    • 8.3.4. South Korea Dural Adhesive Agent for Surgical Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Form
    • 8.3.5. Australia Dural Adhesive Agent for Surgical Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Form

9. Middle East & Africa Dural Adhesive Agent for Surgical Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Type
    • 9.2.3. By Form
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dural Adhesive Agent for Surgical Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Form
    • 9.3.2. UAE Dural Adhesive Agent for Surgical Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Form
    • 9.3.3. South Africa Dural Adhesive Agent for Surgical Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Form

10. South America Dural Adhesive Agent for Surgical Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Type
    • 10.2.3. By Form
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dural Adhesive Agent for Surgical Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Form
    • 10.3.2. Colombia Dural Adhesive Agent for Surgical Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Form
    • 10.3.3. Argentina Dural Adhesive Agent for Surgical Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Form

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dural Adhesive Agent for Surgical Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medprin Biotech GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Integra LifeSciences Corporation
  • 15.3. Pramand LLC
  • 15.4. Stryker Corporation
  • 15.5. DuraStat, Inc.
  • 15.6. Medtronic plc
  • 15.7. Becton, Dickinson and Company
  • 15.8. Regenity Biosciences
  • 15.9. Baxter International, Inc.
  • 15.10. Johnson & Johnson

16. Strategic Recommendations

17. About Us & Disclaimer